Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
125 hedge funds and large institutions have $591M invested in Flexion Therapeutics, Inc. in 2020 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 53 increasing their positions, 22 reducing their positions, and 22 closing their positions.
141% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 22
136% more capital invested
Capital invested by funds: $251M → $591M (+$341M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
14% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 22
2% more funds holding
Funds holding: 123 → 125 (+2)
13% less call options, than puts
Call options by funds: $3.46M | Put options by funds: $4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$16.1M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$14.6M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$13.6M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$13.4M |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$10M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$5.53M |
| 2 |
GS
Gagnon Securities
New York
|
-$5.48M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.23M |
| 4 |
GA
Gagnon Advisors
New York
|
-$3.39M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.22M |
FLXN Hedge Fund Activity: Q2 2020 in Review
125 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q2 2020, worth a combined $591M — up 136% from $251M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new FLXN positions and 22 closed out — a net gain of 3 holders — while 53 added to existing stakes and 22 trimmed.
The largest buyer was OrbiMed, adding an estimated $16.1M. The largest seller was Bank of New York Mellon, cutting an estimated $5.53M.
- 125 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q2 2020, up from 123 in Q1 2020.
- Funds reported $591M of Flexion Therapeutics, Inc. stock for Q2 2020, up 136% quarter-over-quarter.
- 25 funds opened new Flexion Therapeutics, Inc. positions in Q2 2020 and 22 closed out, a net change of +3 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q2 2020 was OrbiMed, an estimated $16.1M added.
- The largest Flexion Therapeutics, Inc. seller in Q2 2020 was Bank of New York Mellon, an estimated $5.53M sold.
Based on aggregated 13F filings for Q2 2020.